EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Newsroom
Company News
Media Report
Company News
More
2026-08-28
CanSinoBIO Expands Innovative Product Portfolio as Internationalization Enters a New Phase — CEO Dr. Xuefeng Yu Speaks with Bloomberg TV
CanSinoBIO and deepGeneAI Explore Collaboration in Personalized mRNA Cancer Vaccines
2026-08-25
CanSinoBIO Showcases Innovative Vaccine Practices at the 12th Asian Congress of Pediatric Infectious Diseases
2026-08-18
CanSinoBIO's Td5cp Vaccine for Adolescents and Adults NDA Accepted by China's NMPA
2026-08-16
CanSinoBIO Signs PCV13
i
LOI with Pakistani Partner to Expand Vaccine Collaboration in South Asia
2026-07-21
CanSinoBIO's Menhycia® Application Accepted by China's NMPA for Expanded Use in Population Aged 3 Months to 17 Years
2026-07-19
Media Report
More
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong
Time：2025-03-28
More
CanSinoBIO to Showcase China’s Vaccine Innovation at 2025 World Government Summit in Dubai
Time：2025-02-14
More
CanSinoBIO Secures Further Funding from the Bill & Melinda Gates Foundation
Time：2024-10-09
Source：ACN Newswire
More
津公网安备12011602300399
